Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Urine Metabolites Associated with Microperimetric Retinal Sensitivity in Age-Related Macular Degeneration
Author Affiliations & Notes
  • Krupa Sourirajan
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Kevin Mendez
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Georgiy Kozak
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Gregory Tsougranis
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Ines Lains
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Haemin Kang
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Augustine Bannerman
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Roshni Bhat
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Hanna Choi
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Archana Nigalye
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Ivana K Kim
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Demetrios G. Vavvas
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • David M Wu
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • John B Miller
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Joan W Miller
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Deeba Husain
    Retina Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Krupa Sourirajan None; Kevin Mendez None; Georgiy Kozak None; Gregory Tsougranis None; Ines Lains None; Haemin Kang None; Augustine Bannerman None; Roshni Bhat None; Hanna Choi None; Archana Nigalye None; Ivana Kim Biophytis, Kodiak Sciences, Code C (Consultant/Contractor); Demetrios Vavvas Olix Pharma, Valitor, TwentyTwenty, Sumitomo/Sunovion, Cambridge Polymer Group, Code C (Consultant/Contractor), National Eye Institute, NIH, Research to Prevent Blindness, Loefflers Family Foundation, Yeatts Family Foundation, and Alcon Research Institute, Code F (Financial Support), Drusolv Therapeutics, Code O (Owner), Massachusetts Eye and Ear, Code P (Patent), Olix Pharma, Valitor, Code S (non-remunerative); David Wu Massachusetts Eye and Ear, Code P (Patent); John Miller Alcon, Allergan, Carl Zeiss, Sunovion, Genentech, and Topcon, Code C (Consultant/Contractor); Joan Miller Genetech/Roche, Heidelberg Engineering, Sunovion, KalVista Pharmaceuticals, ONL Therapeutics, Code C (Consultant/Contractor), Lowy Medical Research Institute, National Eye Institute, Heidelberg Engineering , Code F (Financial Support), Ciendias Bio, Code I (Personal Financial Interest), Drusolv Therapeutics, ONL Therapeutics, Valeant Pharmaceuticals/Mass. Eye and Ear , Code P (Patent), Valeant Pharmaceuticals/Mass. Eye and Ear, KalVista Pharmaceuticals, Sunovion, Aptinyx, Inc. , ONL Therapeutics, Code R (Recipient), Aptinyx, Inc. , ONL Therapeutics, Code S (non-remunerative); Deeba Husain Genentech, Allergan, Novartis, Omeicos Therapeutics, Code C (Consultant/Contractor), NIH, National Eye Institute, Lions Vision Gift, Commonwealth Grant, Lions International, Syneos LLC, and the Macular Society, Code F (Financial Support)
  • Footnotes
    Support  NIH-NEI National Eye Institute 5R01EY030088-03
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3171. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Krupa Sourirajan, Kevin Mendez, Georgiy Kozak, Gregory Tsougranis, Ines Lains, Haemin Kang, Augustine Bannerman, Roshni Bhat, Hanna Choi, Archana Nigalye, Ivana K Kim, Demetrios G. Vavvas, David M Wu, John B Miller, Joan W Miller, Deeba Husain; Urine Metabolites Associated with Microperimetric Retinal Sensitivity in Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3171.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Best-corrected visual acuity (BCVA) has known limitations in patients with age-related macular degeneration (AMD). Microperimetry can represent an alternative reliable measure. Metabolomics, the comprehensive study of metabolites, has revealed significant insights into the pathogenesis of AMD and can contribute to better understand microperimetry changes in this disease. This study aimed to analyze associations between urine metabolites and microperimetry in AMD patients.

Methods : Prospectively recruited cross-sectional study including patients with AMD and a control group (>50 years). All patients were imaged with color fundus photos for AMD classification. Microperimetry was performed using the MAIA microperimetry system (Centervue, Italy), employing a 37-point full-threshold protocol. Fasting blood and urine samples were used for metabolomic profiling (Metabolon Inc). Multilevel mixed-effects linear models were used to assess associations between urine metabolites and retinal sensitivity. Statistical significance was determined by considering the number of independent tests that accounted for 80% of the variance (ENT80).

Results : We included 151 eyes (42 Control, 18 Early AMD, 73 Intermediate AMD, 18 Advanced AMD). Accounting for multiple comparisons, 8 urine metabolites were significantly associated with mean retinal sensitivity (p< 0.0017). These include 3 lysine metabolites (2-oxoadipate, N6-acetyllysine and 5-hydroxylysine), 1 purine metabolite (urate), 1 leucine, isoleucine, and valine metabolite (ethylmalonate), 1 tryptophan metabolite (3-hydroxyanthranilate), 1 progestin steroid (5alpha-pregnan-3beta,20alpha-diol disulfate), and 1 amino sugar metabolite (erythronate). Two of these metabolites were also found in our previous analysis of plasma metabolites.

Conclusions : To our knowledge, we present the first assessment of associations between urinary metabolites and retinal microperimetry sensitivity in AMD, lending credence to our group’s prior research which highlighted the significance of these pathways in AMD's pathophysiology. The most significant urine metabolites were found in Lysine and Tryptophan pathways. Notably the overlap of our prior findings using plasma and urine metabolites suggest that they might play a role in visual impairment and AMD.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×